AGREEMENT TO EXCHANGE WARRANTSAgreement to Exchange Warrants • March 13th, 2020 • Celsion CORP • Pharmaceutical preparations • New York
This is to record the agreement (the “Agreement”) between Celsion Corporation (the “Company”) and the Warrantholders set forth on Schedule I hereto (each a “Warrantholder” and collectively, the “Warrantholders”) regarding the terms on which the Company will issue Exchange Warrants (as defined below) to each Warrantholder in exchange for warrants originally issued pursuant to that Securities Purchase Agreement dated as of February 27, 2020 between the Company and each Warrantholder (the “Securities Purchase Agreement”), as applicable, to purchase shares of common stock and warrants to purchase shares of common stock of the Company. The original warrants were issued to the Warrantholders on March 3, 2020 (the “Original Warrants”). The Company and each Warrantholder hereby agree as follows:
Form of AGREEMENT TO EXHANGE WARRANTSAgreement to Exchange Warrants • September 9th, 2019 • Advaxis, Inc. • Pharmaceutical preparations • New York
This is to record the agreement between Advaxis, Inc. (the “Company”) and [ ] (the “Warrantholder”) regarding the terms on which the Company will issue shares of Common Stock (“Common Stock”), par value $.001 per share, to the Warrantholder in exchange for Warrants (“Warrants”) originally issued under a Warrant Agency Agreement made as of September 11, 2018 between the Company and Continental Stock Transfer and Trust Company entitling the holders to purchase Common Stock, which Agreement is as follows:
FORM OF AGREEMENT TO EXHANGE WARRANTSAgreement to Exchange Warrants • February 21st, 2020 • Ritter Pharmaceuticals Inc • Pharmaceutical preparations • New York
This is to record the agreement between Ritter Pharmaceuticals, Inc. (the “Company”) and _________ (the “Warrantholder”) regarding the terms on which the Company will issue shares of common stock (“Common Stock”), par value $0.001 per share, to the Warrantholder in exchange for warrants originally issued to the Warrantholder on October 30, 2018 (the “2018 Warrants”) entitling the holders to purchase shares of Common Stock, which Agreement is as follows:
AGREEMENT TO EXCHANGE WARRANTSAgreement to Exchange Warrants • January 22nd, 2021 • Advaxis, Inc. • Pharmaceutical preparations • New York
This is to record the agreement between Advaxis, Inc. (the “Company”) and [____] (the “Warrantholder”) regarding the terms on which the Company will issue shares of Common Stock (“Common Stock”), par value $0.001 per share, to the Warrantholder in exchange for warrants originally issued under a Securities Purchase Agreement, dated January 21, 2020, by and among the Company, the Warrantholder and [____] entitling the holders to purchase Common Stock, which Agreement is as follows:
Form of AGREEMENT TO EXHANGE WARRANTSAgreement to Exchange Warrants • June 10th, 2019 • Advaxis, Inc. • Pharmaceutical preparations • New York
This is to record the agreement between Advaxis, Inc. (the “Company”) and [ ] (the “Warrantholder”) regarding the terms on which the Company will issue shares of Common Stock (“Common Stock”), par value $.001 per share, to the Warrantholder in exchange for Warrants (“Warrants”) originally issued under a Warrant Agency Agreement made as of September 11, 2018 between the Company and Continental Stock Transfer and Trust Company entitling the holders to purchase Common Stock, which Agreement is as follows:
